|
|
|
Insider
Information: |
Ho Carole |
Relationship: |
Chief Medical Officer |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
118,810 |
|
Indirect Shares
|
208,219 |
|
|
Direct
Value |
$3,602,319 |
|
|
Indirect Value
|
$6,313,200 |
|
|
Total
Shares |
327,029 |
|
|
Total
Value |
$9,915,519 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
7
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-7.0
|
Percentage
Gain/Loss : |
0.0%
|
-332.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-08-21 |
118,810 |
2024-08-21 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
111 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
107,316 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-05-08 |
4 |
AS |
$23.51 |
$74,339 |
I/I |
(3,162) |
110,332 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
110,597 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-04 |
4 |
AS |
$26.24 |
$252,678 |
I/I |
(9,588) |
113,494 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-08-21 |
4 |
AS |
$24.41 |
$491,571 |
D/D |
(20,005) |
118,810 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-03 |
4 |
AS |
$26.29 |
$252,519 |
I/I |
(9,588) |
123,082 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4 |
AS |
$25.29 |
$238,864 |
I/I |
(9,445) |
132,670 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-08-20 |
4 |
AS |
$23.79 |
$58,357 |
D/D |
(2,453) |
138,815 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
41,120 |
138,967 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-08-13 |
4 |
S |
$22.89 |
$53,494 |
D/D |
(2,337) |
141,268 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-14 |
4 |
AS |
$25.01 |
$12,505 |
I/I |
(500) |
142,115 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-01-02 |
4 |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
142,615 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-02-14 |
4 |
AS |
$17.79 |
$24,995 |
D/D |
(1,405) |
143,605 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-02-13 |
4 |
AS |
$17.29 |
$48,135 |
D/D |
(2,784) |
145,010 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-01-10 |
4 |
AS |
$19.02 |
$88,785 |
D/D |
(4,668) |
147,794 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-12-03 |
4 |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
148,390 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-08-23 |
4 |
AS |
$48.91 |
$300,454 |
I/I |
(6,143) |
158,630 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-03-29 |
4 |
AS |
$54.62 |
$154,126 |
I/I |
(2,822) |
162,319 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
53,720 |
162,434 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-01-05 |
4 |
S |
$44.78 |
$127,399 |
I/I |
(2,845) |
163,285 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-08-19 |
4 |
S |
$49.31 |
$126,230 |
I/I |
(2,546) |
164,773 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-09-10 |
4 |
AS |
$31.00 |
$114,359 |
I/I |
(3,689) |
165,141 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-03-01 |
4 |
AS |
$64.54 |
$470,741 |
I/I |
(7,092) |
165,141 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-11-15 |
4 |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
165,890 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-02-09 |
4 |
S |
$37.10 |
$52,791 |
I/I |
(1,423) |
166,112 |
0 |
- |
|
111 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|